跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Levocent - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Levocent
Approved
STANDARD
Levocent
Akums Drugs & Pharmaceutical Ltd. (Plant III - Injectables)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c78989cbfbe9da9c
Company
Akums Drugs & Pharmaceutical Ltd. (Plant III - Injectables)
Type
Standard
Approval Details
Approval Id
c78989cbfbe9da9c
Drug Approval Philippines Name
Levocent
Product Name
Levocent
Registration Number
DRP-10732-01
Brand Name
Levocent
Generic Name
Levofloxacin
Dosage Form
Solution for I.V. Infusion
Dosage Strength
500 mg / 100 mL (0.5% w/v)
Manufacturer
Akums Drugs & Pharmaceutical Ltd. (Plant III - Injectables)
Importer
S.M.H.P. Marketing & Consultancy
Distributor
Central West Medicale Inc.
Issuance Date
27 October 2024
Expiry Date
09 October 2029
Pharmacologic Category
Antibacterial (Quinolone)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c78989cbfbe9da9c
Type
Standard
Back to Philippines FDA Approvals